Literature DB >> 11272096

Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array.

K T Chen1, J D Lin, T C Chao, C Hsueh, C A Chang, H F Weng, E C Chan.   

Abstract

Patients with follicular thyroid carcinoma have a higher incidence of metastasis than papillary thyroid carcinoma when thyroid cancer is diagnosed. The cDNA expression array technology is utilized herein to profile differentially expressed genes from metastatic human follicular thyroid carcinoma and reveal new tumor markers as well as target genes for therapeutic intervention. Tissue samples were obtained during surgical resection of the thyroid follicular carcinoma and metastatic tissue in the brain of the same patient. Two identical Atlas human cDNA expression arrays were hybridized with 32P-labeled cDNA probes derived from RNA of either primary thyroid cancer or metastatic tissue. Parallel analysis of the hybridized signals allowed us to identify the alteration of gene expression in the metastasis process. Eighteen genes significantly overexpressed and 40 genes significantly underexpressed were identified in the metastatic thyroid cancer. Genes that displayed an altered expression were associated with the processes of cell cycle regulation, apoptosis, DNA damage response, angiogenesis, cell adhesion and mobility, invasion, and immune response. An expression profile of genes that are associated with metastasis process of follicular thyroid cancer was also discussed. Further investigation is required to understand the precise relationship between the altered expression of these genes and the metastasis process of follicular thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272096     DOI: 10.1089/10507250150500658

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

1.  Proteomic analysis of human thyroid cell lines reveals reduced nuclear localization of Mn-SOD in poorly differentiated thyroid cancer cells.

Authors:  D Russo; A Bisca; M Celano; F Talamo; F Arturi; A Scipioni; I Presta; S Bulotta; E Ferretti; S Filetti; A Scaloni; G Damante; G Tell
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

2.  Differential effects of cetuximab and AEE 788 on epidermal growth factor receptor (EGF-R) and vascular endothelial growth factor receptor (VEGF-R) in thyroid cancer cell lines.

Authors:  S Hoffmann; A Burchert; A Wunderlich; Y Wang; S Lingelbach; L C Hofbauer; M Rothmund; A Zielke
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

3.  Discrimination of benign and malignant thyroid nodules by molecular profiling.

Authors:  David J Finley; Baixin Zhu; Catherine B Barden; Thomas J Fahey
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

Review 4.  New molecular methods for classification, diagnosis and therapy prediction of hematological malignancies.

Authors:  Agnes Zvara; László Hackler; Zsolt B Nagy; Tamás Micsik; László G Puskás
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 2.874

5.  A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.

Authors:  Krzysztof Fujarewicz; Michal Jarzab; Markus Eszlinger; Knut Krohn; Ralf Paschke; Małgorzata Oczko-Wojciechowska; Małgorzata Wiench; Aleksandra Kukulska; Barbara Jarzab; Andrzej Swierniak
Journal:  Endocr Relat Cancer       Date:  2007-09       Impact factor: 5.678

Review 6.  Bone metastases in thyroid cancer.

Authors:  Nicole M Iñiguez-Ariza; Keith C Bible; Bart L Clarke
Journal:  J Bone Oncol       Date:  2020-02-19       Impact factor: 4.072

7.  Novel nomogram to predict risk of bone metastasis in newly diagnosed thyroid carcinoma: a population-based study.

Authors:  Yuexin Tong; Chuan Hu; Zhangheng Huang; Zhiyi Fan; Lujian Zhu; Youxin Song
Journal:  BMC Cancer       Date:  2020-11-03       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.